General Information
All solvents were dried before use following the standard procedures. Unless otherwise indicated, all starting materials purchased from commercial suppliers were used without further purification. The 1 H and 13 C NMR spectra were recorded on Bruker AV-400 MHz in the indicated solvents. Chemical shifts are reported in δ (ppm) referenced to an internal TMS standard for 1 H NMR and CDCl 3 (δ = 77.10 ppm) for 13 C NMR. Coupling constants (J) are quoted in Hz. IR spectra were recorded on Nicolet iN 10 MX. ESI mass spectra were recorded on Agilent 1200/G6100A. (BOP = Benzotriazol-1-yloxytris(dimethylamino) phosphoniumhexafluorophosphate; DIPEA = Ethyldiisopropylamine; DMAP = 4-Dimethylaminopyridine; MsCl = Methanesulfonyl chloride;
Ligand Preparation

General Procedure for Preparation of TOlefOx Type I Ligands
To a well-stirred solution of enoic acid 4 [1] (1 mmol) in DCM / DMF (20:3, 10 mL) was added the optically pure amino alcohol 5 (1 mmol), BOP (1.2 mmol) and DIPEA (2 mmol). The resulted solution was stirred overnight at room temperature. Then the reaction mixture was diluted with water (30 mL) and extracted with DCM (30 mL × 3). The combined organic phases were washed with brine (30 mL), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The residue was used in the next step without any further purification. To a well-stirred solution of the previous residue, Et 3 N (8 mmol) and DMAP (0.1 mmol) in DCM (10 mL) was added MsCl (2.5 mmol) dropwise at 0 o C. The resulting solution was warmed to room temperature and stirred overnight. The reaction mixture was quenched with water (30 mL) and extracted with DCM (30 mL × 3). The combined organic phases were washed with brine (30 mL), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The residue was purified by flash column chromatography using hexane / ethyl acetate eluent to afford the desired product L1−L3. [1] 2,2-Dimethylbut-3-enoic acid (4a, CAS 10276-09-2), 2,2-Dimethylpent-4-enoic acid (4b, CAS 16386-93-9) , and (S)-Phenylalaninol (5a, CAS 3182-95-4) were purchased from Alfa Aesar. (S)-Diphenylalaninol (5b, CAS 162118-01-6) was purchased from Oakwood Chemical.
S4
(S)-4-Benzyl-2-(2-methylbut-3-en-2-yl)- 172.16, 143.27, 141.83, 129.02, 128.39, 126.66, 112.27, 70.80, 69.12, 56.03, 39.17, 25.22, 25.02 85, 137.62, 134.26, 129.26, 128.22, 126.23, 117.39, 71.14, 66.78, 44.74, 41.50, 36.26, 25.24, 25.22 92, 141.90, 134.65, 129.09, 128.16, 126.54, 117.39, 70.57, 69.24, 56.25, 44.80, 36.38, 25.30, 25.26 4, 1657.6, 1599.9, 1494.8, 1354.8, 1214.0, 987.5, 914.5, 833.3, 700.5, 560.7 
General Procedure for Preparation of TOlefOx Type II Ligands
To a well-stirred solution of the optically pure amino acid 6 [2] (1 mmol) in THF (10 mL) under argon atmosphere was added LiAlH 4 (2 mmol) in several portions at 0 °C and allowed to stir for 2 h. The resulting solution was warmed to room temperature and stirred for 36 h. The reaction mixture was quenched with 10% NaOH aqueous solution (30 mL) and extracted with ethyl acetate (30 mL × 3). The combined organic phases were washed with brine (30 mL), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure to afford the crude compound 7, which was used in the next step without any further purification. To a well-stirred solution of the crude compound 7 in DCM / DMF (20:3, 10 mL) was added the carboxylic acid 8 (1 mmol), BOP (1.2 mmol) and DIPEA (2 mmol). The resulted solution was stirred overnight at room temperature. Then the reaction mixture was diluted with water (30 mL) and extracted with DCM (30 mL × 3). The combined organic phases were washed with brine (30 mL), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The residue was used in the next step without any further purification.
To a well-stirred solution of the previous residue, Et 3 N (8 mmol) and DMAP (0.1 mmol) in DCM (10 mL) was added MsCl (2.5 mmol) dropwise at 0 o C. The resulting solution was warmed to room temperature and stirred overnight. The reaction mixture was quenched with water (30 mL) and extracted with DCM (30 mL × 3). The combined organic phases were washed with brine (30 mL), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The residue was purified by flash column chromatography using hexane / ethyl acetate eluent to afford the desired product L4−L9.
(S)-4-Allyl-2-benzyl-4,5-dihydrooxazole (L4)
Colorless oil. 32% yield for three steps. 
S6
166. 30, 135.27, 134.07, 128.96, 128.61, 127.01, 117.64, 71.93, 65.47, 39.81, 34.88 
Preparation Of L10
The preparation of compound 6d followed the procedure of Rodney and coworkers [3] . The preparation of L10 followed the general procedure for preparation of TOlefOx type II ligands. 66, 139.34, 139.13, 136.67, 133.41, 130.92, 128.78, 128.61, 128.37, 128.36, 128.09, 127.00, 126.90, 126.47, 119.01, 73.22, 73.10, 51.03, 45.16, 44.78 3027.6, 2976.9, 1660.4, 1601.6, 1494.9, 1452.7, 1363.2, 1181.8, 1031.3, 992.6, 918.2, 749 .6, 700.1. 
Preparation of L11
The preparation of compound 9 followed the procedure of Koskinen and coworkers [4] .
(S)-Methyl 4-allyl-2-benzhydryl-4,5-dihydrooxazole-4-carboxylate (10)
To a well-stirred solution of compound 9 (8.5 mmol) in MeOH (40 mL) under argon atmosphere was added HCl (2M, 16 mL) dropwise in an hour at room temperature. The resulting solution was allowed to stir overnight at room temperature. Then the reaction mixture was quenched with saturated NaHCO 3 (50 mL) and evaporated the solvent MeOH in vacuo, then extracted with ethyl acetate (50 mL × 3), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure to afford the crude compound 7e. The residue was used in the next step without any further purification. The preparation of 10 followed the general procedure for preparation of TOlefOx type I ligands to afford the desired product 10 as white solid, 29% yield for three steps. 
R)-4-Allyl-2,4-dibenzhydryl-4,5-dihydrooxazole (L11)
To a well-stirred solution of compound 10 (1 mmol) in THF (10 mL) under argon atmosphere was added phenylmagnesium bromide (3.0 M solution in diethyl ether, 1 mL, 3.0 mmol) and allowed to stir for 10 min at room temperature. Then the reaction mixture was quenched with saturated NH 4 Cl solution (50 mL) extracted with ethyl acetate (50 mL × 3). The combined organic phases were washed with brine (20 mL), dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure to afford the crude compound 11. To a well-stirred solution of the previous crude compound 11 in THF (10 mL) under argon atmosphere was added Et 3 SiH (30 mmol) and AlCl 3 (1.5 mmol) [ 166.72, 141.40, 140.67, 139.64, 139.29, 133.45, 130.20, 128.98, 128.78, 128.41, 128.24, 127.04, 126.93, 126.54, 119.08, 76.14, 73.19, 59.81, 51.24, 44.34 
General Procedure of Rh-Catalyzed Conjugate Addition
A dried Schlenk flask was charged with [Rh(C 2 H 4 ) 2 Cl] 2 (5 mol% Rh), L (10 mol%), arylboronic acid 2 (0.4 mmol) in toluene / H 2 O (1mL / 0.1mL), the reaction mixture was stirred at room temperature for 15 min under argon atmosphere. Then the base (30 mol%) and enone 1 (0.2 mmol) were added and allowed to stir at room temperature. After the reaction was finished tracked by TLC, the reaction mixture was quenched with saturated aqueous NH 4 Cl (5 mL) and extracted with ethyl acetate (5 mL × 3). The organic phase was washed with brine, dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The residue was purified by flash column chromatography using hexane / ethyl acetate eluent to afford the desired product 3.
(R)-3-Phenylcyclohexanone (3aa) [5] 33.6 mg, 97% yield. 
Preparation of [Rh(L10)(acac)] and [Rh(L11)(acac)]
To a small vessel was added [Rh(C 2 H 4 ) 2 (acac)] (10 mg, 0.04 mmol), L10/L11 (0.056 mmol, 1.4 equiv) and 1,4-dioxane (0.1 mL). The small vessel was placed in a sealed bottle, which was charged with n-pentane (5 mL). After the solvent exchange of 1,4-dioxane and n-pentane for 4 days, the red-brown crystals were obtained. (R) Ph Ph
X-Ray
